What is ELVN (ELVN) stock price today?

ELVN (ELVN) is currently trading at $57.86, down 0.05% today.

What is ELVN P/E ratio?

ELVN's P/E ratio is -34.70. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ELVN return on equity (ROE)?

ELVN's return on equity (ROE) is -18.55%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is ELVN's market cap?

ELVN has a market capitalization of $4.13B.

NASDAQ · Biotechnology

ELVN (ELVN) Stock

$57.86 -0.05% NASDAQ: ELVN Healthcare

Valuation

Metric	Value
Price	$57.86
Market Cap	$4.13B
P/E Ratio	-34.70
P/B Ratio	4.21
P/S Ratio	0.00
EPS (TTM)	$-1.64
52-Week High	$62.32
52-Week Low	$14.79
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-18.55%
ROA	-11.64%
ROCE	-13.88%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	40.32

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-25.0M	$-39.0M	$-84.0M	$-105.0M	$-120.0M
Net Profit	$-25.0M	$-38.0M	$-72.0M	$-89.0M	$-104.0M
EPS	$-3.17	$-6.03	$-2.01	$-1.89	$-1.83
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$113.0M	$83.0M	$272.0M	$326.0M	$476.0M
Total Liabilities	$6.0M	$160.0M	$26.0M	$16.0M	$17.0M
Cash	$110.0M	$76.0M	$100.0M	$124.0M	$99.0M
Borrowings	$0	$0	$0	$0	$0

Latest News

HMI Capital Pares Its Stake in AI Company nCino Barrons.com · Jul 10, 2026 Enliven Therapeutics Insider Sold Shares Worth $504,903, According to a Recent SEC Filing MT Newswires · Jul 8, 2026 Stocks To Watch: 14 Names Test And Tease New Buy Zones Investor's Business Daily · Jul 8, 2026 Enliven Therapeutics (ELVN) Stock Looks Overvalued As Returns Surge But Book Value Lags Simply Wall St. · Jul 4, 2026 What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130% Motley Fool · Jun 27, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-19.0M	$-32.0M	$-61.0M	$-73.0M	$-70.0M
Investing Cash Flow	$0	$-1.0M	$-149.0M	$-36.0M	$-174.0M
Financing Cash Flow	$0	$-1.0M	$73.0M	$94.0M	$0
Net Cash Flow	$-20.0M	$-34.0M	$25.0M	$24.0M	$-25.0M
Free Cash Flow	$-19.0M	$-33.0M	$-61.0M	$-73.0M	$-70.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-1.75
EV / EBITDA	-37.15
FCF Yield	-1.65%
Quick Ratio	64.07
Interest Coverage	0.00
Return 1Y	184.18%
Return 3Y	256.28%
Return 5Y	214.58%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ATAI	$7.34	+0.00%	-8.44	$2.72B	0.00%
DNTH	$106.62	+0.96%	-812.38	$5.96B	0.00%
IMTX	$9.43	-1.05%	-4.98	$1.26B	0.00%
INBX	$124.66	-1.61%	-14.11	$1.83B	0.00%
NKTR	$71.75	+0.52%	-6.95	$2.06B	0.00%

About ELVN

ELVN stock trades at $57.86 with a market capitalization of $4.13B. The stock is valued at a price-to-earnings (P/E) ratio of -34.70, price-to-book of 4.21, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $14.79 and $62.32, and currently trades 7.2% below its 52-week high.

On profitability, ELVN generates a return on equity (ROE) of -18.55%, return on capital employed of -13.88%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides